Top

Archives of Gynecology and Obstetrics

Published in:

01-10-2011 | Reproductive Medicine

A randomized trial of ovulation induction with two different doses of Letrozole in women with PCOS

Authors: Fatemeh Ramezanzadeh, Roya Nasiri, Mohammad Sarafraz Yazdi, Maryam Baghrei

Published in: Archives of Gynecology and Obstetrics | Issue 4/2011

Abstract

Objective

To compare the effects of either a 5 or 7.5 mg daily dose of Letrozole in PCOS women undergoing ovulation induction and timed intercourse.

Design

Prospective randomized trial.

Setting

Academic infertility care center.

Patients

Sixty-seven PCOS patients with infertility.

Interventions

Patients were randomly divided into two groups and treated with either 5 mg/day (30 patients, group 1) or 7.5 mg/day (37 patients, group 2) Letrozole for 5 days starting from day 3 of the menstrual cycle. When the leading follicle reached 18 mm in diameter, ovulation was triggered by an injection of HCG and timed intercourse was advised thereafter.

Main outcome measures

The primary outcome measures were the number of follicles and days to reach mature follicle and the secondary endpoints were endometrial thickness, day 7 testosterone level, ovulation and pregnancy rates.

Results

The mean age, BMI, duration of infertility and basal hormone levels in both groups were similar. There was no significant difference in the endometrial thickness (7.87 ± 1.67 vs 7.16 ± 2.04), the number of intermediate (0.83 ± 0.75 vs 0.62 ± 0.76) and mature follicles (1.13 ± 1.11 vs 1.22 ± 1.03) on days 12–14 between group 1 and 2, respectively. The days to reach mature follicle were similar in both groups (12.8 ± 1.36 vs 12.6 ± 1.22). Also there was no significant difference in the day 7 testosterone level and day 21 progesterone level between the two. Ovulation occurred in 90 and 89.2% of patients in group 1 and 2, respectively without a statistically significant difference. The pregnancy rate per first ovulatory cycle was 25.8% in group 1 and 21.2% in group 2 without significant difference. No OHSS was observed in either group.

Conclusion(s)

The results of this study did not show any advantage to the use of 7.5 mg/day over 5 mg/day dose of Letrozole as the first line treatment for induction of ovulation in women with PCOS.

Young SL, Opsahl MS, Fritz MA (1999) Serum concentrations of enclomiphene and zuclomiphene across consecutive cycles of clomiphene citrate therapy in anovulatory infertile women. Fertil Steril 71(4):639–644PubMedCrossRef

Mikkelson TJ, Kroboth PO, Cameron WJ, Dittert LW, Chungi Y, Manberg PJ (1986) Single-dose pharmacokinetics of clomiphene citrate in normal volunteers. Fertil Steril 46(3):392–396PubMed

Gonen Y, Casoer RF (1990) Sonographic determination of an adverse effect of clomiphene citrate on endometrial growth. Hum Reprod 5(6):670–674PubMed

Sereepapong W, Triratanachat S, Sampatanukul P, Pruksananonda K, Boonkasemsanti K, Reinprayoon D (2000) Effects of clomiphene citrate on the endometrium of regularly cycling women. Fertil Steril 73(2):287–291PubMedCrossRef

Homburg R (2005) Clomiphene citrate—end of an era? a mini-review. Hum Reprod 20(8):2043–2051 Epub 2005 May 5PubMedCrossRef

Al-Fozan H, Al-Khadouri M, Tan SL, Tulandi T (2004) A randomized trial of Letrozole versus clomiphene citrate in women undergoing superovulation. Fertil Steril 82(6):1561–1563PubMedCrossRef

Franks S, Adams J, Mason H, Polson D (1985) Ovulatory disorders in women with polycystic ovary syndrome. Clin Obstet Gynecol 12(3):605–632

Kistner RW (1965) Induction of ovulation with clomiphene citrate (clomid). Obstet Gynecol Survey 20(6):873–900CrossRef

Mitwally M, Biljan M, Casper R (2005) Pregnancy outcome after the use of an aromatase inhibitor for ovarian stimulation. Am J Obstet Gynecol 192(2):381–386PubMedCrossRef

10.

Mitwally M, Casper RF (2000) Aromatase inhibition: a novel method of ovulation induction in women with polycystic ovarian syndrome. Reprod Technol 10:244–247

11.

Mitwally M, Casper R (2001) Use of aromatase inhibitor for ovulation induction in patients with an inadequate response to clomiphene citrate. Fertil Steril 75(2):305–309PubMedCrossRef

12.

Casper RF (2003) Letrozole: ovulation or superovulation? Fertil Steril 80(6):1335–1337 discussion 1339PubMedCrossRef

13.

Casper RF, Mitwally MF (2006) Review: aromatase inhibitors for ovulation induction. J Clin Endocrinol Metab 91(3):760–771 Epub 2005 Dec 29PubMedCrossRef

14.

Baruah J, Roy kk, Rahman SM, Kumar S, Sharma JB, Karmakar D (2009) Endometrial effects of Letrozole and clomiphene citrate in women with polycystic ovary syndrome using spiral artery Doppler. Arch Gynecol Obstet 279(3):311–314 Epub 2008 Jul 3PubMedCrossRef

15.

Badawy A, Aal IA, Abulatta M (2009) Clomiphene citrate or Letrozole for ovulation induction in women with polycysiic ovarian syndrome: a prospective rundomized trial. Fertil Steril 92(3):849–852PubMedCrossRef

16.

Begum MR, Ferdous J, Begum A, Quadir E (2009) Comparison of efficacy of aromatase inhibitor and clomiphene citrate in induction of ovulaltion in polycystic ovarian syndrome. Fertil Steril 92(3):853–857PubMedCrossRef

17.

Sohrabvand F, Ansari Sh, Bagheri M (2006) Efficacy of combined metformin–Letrozole in comparison with metformin–clomiphene citrate in clomiphene-resistant infertile women with polycystic ovarian disease. Hum Reprod 21(6):1432–1435PubMedCrossRef

18.

Atay V, Cam C, Muhcu M, Cam M, Karateke A (2006) Comparison of Letrozole and clomiphene citrate in women with polycystic ovaries undergoing ovarian stimulation. J Int Med Res 34(1):73–76PubMed

19.

Ganesh A, Goswami SK, Chattopadhyay R, Chaudhury K, Chakravarty B (2009) Comparison of Letrozole with continuous gonadotropins and clomiphene-gonadotropin combination for ovulation induction in 1387 PCOS women after clomiphene citrate failure: a randomized prospective clinical trial. J Assist Reprod Genet 26(1):19–24 Epub 2009 Jan 7PubMedCrossRef

20.

Bayar U, Basaran M, Kiran S, Coskun A, Gezer S (2006) Use of an aromatase inhibitor in patients with polycystic ovary syndrome: a prospective randomized trial. Fertil Steril 86(5):1447–1451PubMedCrossRef

21.

Zeinalzadeh M, Basirat Z, Esmailpour M (2010) Efficacy of Letrozole in ovulation induction compared to that of clomiphene citrate in patients with polycystic ovarian syndrome. J Reprod Med 55(1–2):36–40PubMed

22.

Abu Hashim H, Shokeir T, Badawy A (2010) Letrozole versus combined metformin and clomiphene citrate for ovulation induction in clomiphene-resistant women with polycystic ovary syndrome: a randomized controlled trial. Fertil Steril 94(4):1405–1409 Epub 2009 Sep 3PubMedCrossRef

23.

Yang MQ, Quan S, Li H, Song YL, Xing FQ (2008) Effect of two different doses of Letrozole in promoting ovulation in infertile women with polycystic ovarian syndrome. Nan Fang Yi Ke Da Xue Xue Bao 28(11):2060–2061PubMed

24.

Al-Fadhli R, Sylvestre C, Buckett W, Tan SL, Tulandi T (2006) A randomized trial of superovulation with two different doses of Letrozole. Fertil Steril 85(1):161–164PubMedCrossRef

25.

The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group, Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (2004) Fertil Steril 81(1):19–25

26.

Guzick D (1998) Polycystic ovary syndrome.symptomatology,pathophysiology and epidemiology. Am J Obstet Gynecol 179(6 Pt 2):S89–S93PubMedCrossRef

27.

Casper RF (2009) Letrozole versus clomiphene citrate: which is better for ovulation induction? Fertil Steril 92(3):858–859 (Epub 2007 Jun 27)PubMedCrossRef

28.

Tulandi T, Martin J, Al-Fadhli R, Kabli N, Forman R, Hitkari J et al (2006) Congenital malformations among 911 newborns conceived after infertility treatment with Letrozole or clomiphene citrate. Fertil Steril 85(6):1761–1765 (Epub 2006 May 2)PubMedCrossRef

29.

Badawy A, Shokeir T, Allam AF, Abdelhady H (2009) Pregnancy outcome after ovulalion induction with aromatase inhibitors or clomiphene citrate in unexplained infertility. Acta Obstet Gynecol Scand 88(2):187–191PubMedCrossRef

30.

Badawy A, Mosbah A, Tharwat A, Eid M (2009) Extended Letrozole therapy for ovulation induction in clomiphene-resistant women with polycystic ovary syndrome: a novel protocol. Fertil Steril 92(1):236–239 (Epub 2008 Aug 15)PubMedCrossRef

31.

Ramezanzadeh F, Seifi J, Masumi M, Jafarabadi M (2007) Single dose Letrozole versus 5 day course in ovulation induction for in vivo fertilization. Hum Reprod 22(Suppl 1):IJ36

32.

Badawy A, Mitwally M, Fawzy M (2007) Randomized controlled trial of three doses of Letrozole for ovulation induction in patients with unexplained inferlilily. Reprod Biomed Online 14(5):559–562PubMedCrossRef

33.

Messinis IE (2005) Ovulation induction: a mini review. Hum Reprod 20(10):2688–2697PubMedCrossRef

34.

Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Consensus on infertility treatment related to polycystic ovary syndrome (2008). Fertil Steril 89(3):505–5022. (Epub 2008 Feb 20)

Title: A randomized trial of ovulation induction with two different doses of Letrozole in women with PCOS
Authors: Fatemeh Ramezanzadeh
Roya Nasiri
Mohammad Sarafraz Yazdi
Maryam Baghrei
Publication date: 01-10-2011
Publisher: Springer-Verlag
Published in: Archives of Gynecology and Obstetrics / Issue 4/2011
Print ISSN: 0932-0067
Electronic ISSN: 1432-0711
DOI: https://doi.org/10.1007/s00404-011-1951-5

Keynote webinar | Spotlight on medication adherence

Springer Medicine

A randomized trial of ovulation induction with two different doses of Letrozole in women with PCOS

Abstract

Objective

Design

Setting

Patients

Interventions

Main outcome measures

Results

Conclusion(s)

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Objective

Design

Setting

Patients

Interventions

Main outcome measures

Results

Conclusion(s)

Please log in to get access to this content

Other articles of this Issue 4/2011

Correlation between breast arterial calcification detected on mammography and cerebral artery disease

Anatomical study of position of the TVT-O to the obturator nerve influenced by the position of the legs during the procedure: based upon findings at formalin-embalmed and fresh-frozen bodies

Reply: Placenta previa and perinatal mortality

Transvaginal ultrasound of cervical length and its correlation to digital cervical examination, time to spontaneous labor and mode of delivery

Does cervical length and the lower placental edge thickness measurement correlates with clinical outcome in cases of complete placenta previa?

Maternal early pregnancy body mass index and risk of preterm birth